A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ARD-101 FOR THE TREATMENT OF HYPERPHAGIA IN PATIENTS WITH PRADER -WILLI SYNDROME

Registry ID

AVK-101-301

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE3

Study type

INTERVENTIONAL

Sponsor

AARDVARK THERAPEUTICS INC

Start date

2026-02-03

Last update

2025-10-24

Conditions

• PRADER-WILLI SYNDROME

Related clinical trials

• A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, EFFICACY AND SAFETY STUDY OF PITOLISANT FOLLOWED BY AN OPEN-LABEL EXTENSION IN PATIENTS WITH PRADERWILLI SYNDROME

View on source registry